6OCTOBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIt is no secret that the year 2020 was adverse for many businesses, but on the other hand, it also opened the doors to change and improvement. The pharma sector especially, after suffering a crippling blow to its traditional sales and marketing methods, shifted its focus on the far more effective medium--digital, a channel long ignored by the industry. `Digital' is now here to stay and set to become an indispensable part of the overall pharma marketing efforts.In fact, `digital' is now an integral part of the overall sales and marketing blueprint of pharmaceutical companies, and most of the larger organizations have appointed dedicated digital heads and leads. Today, digitalization could be in the form of mobile-driven content programs or a shift to an always-open customer service channel via a website or Facebook Live chat to target the pharmaceutical organizations via social media and other digital communities that makes targeted networking possible. Besides this, organizations can also leverage AI and cloud platforms to reach larger audience.Now, it is only a question of whether organizations are ready to invest in the future of pharma marketing. In this edition of Pharma Tech Outlook, we bring you the story of some of the most promising pharma marketing service companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best pharma marketing solution provider according to your requirements.Let us know your thoughts!Digitalizing Pharma Tactics to Capture the Post-Pandemic MarketCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 04 - 2021, Vol 07 - Issue 09 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerChris LynnEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >